Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
Breast Cancer Research and Treatment|July 27, 2021
Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 womenD Gareth Evans, Sacha J Howell, Ashu Gandhi, et al.Familial Cancer|March 25, 2021
Extended gene panel testing in lobular breast cancerElke M van Veen, D Gareth Evans, Elaine F Harkness, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 15, 2022
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panelD Gareth R Evans, Elke M van Veen, Elaine F Harkness, et al.Cancer Discovery|April 16, 2015
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell CarcinomaMariam Jafri, Naomi C Wake, David B Ascher, et al.Trials|February 2, 2024
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocolMiriam Dixon-Zegeye, Rachel Shaw, Linda Collins, et al.British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.Cancers|February 11, 2023
Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2024
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition geneRobert D Morgan, George J Burghel, Nicola Flaum, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.Pageof 9